The International Contrast Ultrasound Society (ICUS)

  • Increase font size
  • Default font size
  • Decrease font size
Home News

The News

Shockwaves subside from the FDA's Echo Contrast Warning

E-mail Print PDF
Cardiovascular Business article available here
 

ICUS Newsletters

E-mail Print PDF

January 2009

December 2008

 

EFSUMB Newsletter meets ICUS

E-mail Print PDF

European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) Newsletter meets ICUS - The International Contrast Ultrasound Society

New International Contrast Ultrasound Society (ICUS) founding member and Co-President, Dr. Steven Feinstein, interviewed by Professor Michael Bachmann Nielsen December 2008.

Steven Feinstein is a cardiologist specializing in prevention and noninvasive diagnosis of cardiovascular abnormalities. He also serves as director of the echocardiography laboratory at Rush University Medical Center in Chicago. Dr. Feinstein has worked in the contrast-enhanced ultrasound (CEUS) field for approximately 26 years and developed the first two FDA approved ultrasound contrast agents, Albunex and Optison. He currently coordinates international research teams using CEUS to investigate vessel wall biology and identify early CV disease using surrogate markers of atherosclerosis, including myocardial perfusion, carotid IMT, and neovascularization (intra-plaque and adventitial vasa vasorum).

The full interview is available for download as a PDF here

Last Updated ( Tuesday, 08 December 2009 17:17 )
 

ICUS Founding Sponsors

Banner
Banner
Banner

 

Interested in becoming an ICUS sponsor? Click here to find out how!